Open Access

Effect of aromatase inhibitor letrozole on the proliferation of spermatogonia by regulating the MAPK pathway

  • Authors:
    • Shunde Wang
    • Shuhong Wang
    • Hang Li
    • Xiaoxia Li
    • Menglin Xie
    • Jiayu Wen
    • Meicai Li
    • Tengbo Long
  • View Affiliations

  • Published online on: April 20, 2018     https://doi.org/10.3892/etm.2018.6081
  • Pages: 5269-5274
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The molecular mechanism of the aromatase inhibitor letrozole was investigated. It promotes the proliferation of spermatogonia by regulating the mitogen‑activated protein kinase (MAPK) pathway. Six different concentrations were selected for letrozole in order to incubate mouse spermatogonia [GC-1 spermatogonia (spg)] for 24, 48 and 72 h, respectively. Cell Counting Kit-8 (CCK-8) was used to observe the effect of letrozole on the proliferation of GC-1 spg cells, and the effect was further verified by cell plate clone formation assay. Reverse transcription-polymerase chain reaction (RT-PCR) and western blot analysis were used to detect the effects of letrozole on MAPK signaling pathways [Ras/extracellular signal-regulated kinase 1 (ERK1)/c-Myc], proliferation indexes [Ki-67 and proliferating cell nuclear antigen (PCNA)]. Bromodeoxyuridine (BrdU) staining was used to study the effects of letrozole and MAPK signaling pathways on cell proliferation. The results of CCK-8 showed that the proliferation rate of GC-1 spg cells was improved. Study results also revealed a significant increase in letrozole concentration along with the time of action. The results of plate clone formation assay further indicated that letrozole could significantly promote the proliferation capacity of GC-1 spg cells (p<0.05). The results of RT-PCR and western blot analysis confirmed letrozole significantly activated the expression of Ras/ERK1/c-Myc in the classical MAPK pathway. A significant increase was noted in the protein levels of Ki-67 and PCNA (p<0.05). By contrast, inhibition of the MAPK pathway resulted in a significant decrease in the levels of the above indexes (p<0.05). The number of BrdU cells in the letrozole group was also higher than that of the control group, while the number of BrdU‑stained cells in the letrozole + MAPK inhibition group showed a significant decrease in comparison to the letrozole group. In conclusion, letrozole activated the MAPK signaling pathway and promoted the proliferation of mouse spermatogonia GC-1 spg cells. The present study provides a theoretical basis for the clinical application of letrozole.
View Figures
View References

Related Articles

Journal Cover

June-2018
Volume 15 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang S, Wang S, Li H, Li X, Xie M, Wen J, Li M and Long T: Effect of aromatase inhibitor letrozole on the proliferation of spermatogonia by regulating the MAPK pathway. Exp Ther Med 15: 5269-5274, 2018
APA
Wang, S., Wang, S., Li, H., Li, X., Xie, M., Wen, J. ... Long, T. (2018). Effect of aromatase inhibitor letrozole on the proliferation of spermatogonia by regulating the MAPK pathway. Experimental and Therapeutic Medicine, 15, 5269-5274. https://doi.org/10.3892/etm.2018.6081
MLA
Wang, S., Wang, S., Li, H., Li, X., Xie, M., Wen, J., Li, M., Long, T."Effect of aromatase inhibitor letrozole on the proliferation of spermatogonia by regulating the MAPK pathway". Experimental and Therapeutic Medicine 15.6 (2018): 5269-5274.
Chicago
Wang, S., Wang, S., Li, H., Li, X., Xie, M., Wen, J., Li, M., Long, T."Effect of aromatase inhibitor letrozole on the proliferation of spermatogonia by regulating the MAPK pathway". Experimental and Therapeutic Medicine 15, no. 6 (2018): 5269-5274. https://doi.org/10.3892/etm.2018.6081